On December 14th, 2021, Vietnam Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious pharmaceutical companies in 2021. Accordingly, Traphaco Joint Stock Company is honored to be in the Top 10 Prestigious Pharmaceutical Companies and 1st Top 5 Prestigious Oriental Pharmaceutical Companies in 2021.
Top 10 prestigious pharmaceutical companies are built based on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown in the latest year’s financial statements; (2) Media credibility is assessed by Media Coding method – encoding articles about the company on influential media channels; (3) Survey of stakeholders was carried out in November 2021.
List: Top 10 prestigious pharmaceutical manufacturing companies in 2021
List: Top 5 prestigious Vietnamese oriental pharmaceutical companies in 2021
This result has confirmed the financial capacity, media credibility, and the trust of stakeholders and the social community for Traphaco JSC in 2021, a year full of changes and challenges.
Traphaco makes a breakthrough in 2021 thanks to flexible adaptation during the pandemic
2021 is the year of building and deploying Traphaco culture in a new phase. The 6 ultimate cultural principles Honesty, Courage, Proactivity, Connection, Creativity and Responsibility of Traphaco culture are being realized in work, in production and business, thereby creating a healthy working environment, enhancing the initiative and creativity of employees.
The company carried out a project to standardize many work processes according to the recommendations of the consultant. Coherence, teamwork, synchronization in resource planning and market availability, adherence to practice have been significantly improved, eliminating activities that do not bring value. The standardization of the process so far has achieved certain results, setting the stage for a strong restructuring next year.
The ability to flexibly adapt to the epidemic situation is clearly demonstrated in the following points.
In terms of production, “3 on-site” was established in a timely manner at Traphaco Hung Yen and Traphaco CNC factories. The factory has arranged resting places for employees, preparing more personal items such as: personal curtains, mats, blankets; arrange hot water dispensers in bathrooms so that employees have favorable living conditions. Performing 5K during work process. Well organize a safe kitchen, install a glass panel to separate each person, eating according to the time frame; register for employees to be vaccinated against Covid-19.
In terms of sales, the sales department quickly changed its approach to customers, instead of directly visiting customers, switching to selling by phone, zalo, etc. The pharmacy support programs were built with focus according to the epidemic, stabilizing selling prices, deploying many promotions and gifts; Marketing tools are designed to suit the online sales scenario, helping the Pharmacist to be proactive in his work.
Faced with the risk of social distancing and supply chain disruption, the Company proactively conducted active production and shipped products to provinces before the epidemic broke out. Therefore, when the situation of social distancing, travel restrictions, difficult transportation, 3 on-site production, Traphaco has enough products in the provinces, this helps the Company to proactively supply in a timely manner, helping growth even in provinces that are the epicenter of the epidemic such as Binh Duong, Long An, and Ho Chi Minh City. Ho Chi Minh.
Regarding community activities, Traphaco is interested in sharing with community groups such as: supporting mouthwash products for F0 treatment bags (Ministry of Health), supporting the Covid-19 vaccine fund, participating in Project of Sampling chamber against heat for doctors and nurses, there were many rounds of donation of epidemic prevention products to hospitals and pharmacies nationwide, maintaining the procurement of medicinal herbs for ethnic minorities.
With the best efforts of all employees, the leadership of the Board of Directors and the Board of Managements of the company, it is estimated that Traphaco’s business results in 2021 will achieve compound growth: 11-month revenue reaches 2000 billion reaching 95% of the plan (2100 billion), it is expected that by the end of 2021, the revenue will reach VND 2170 billion, exceeding 4% of the plan and increasing by 14% over the same period; Profit after tax is expected to reach VND 265 billion, exceeding 10% of the plan and growing by 25%. Employee income increased by over 10% compared to 2020. This is a favorable start for the 2021-2025 term, a driving force for Traphaco to enter a new business cycle, with clear business goals and strategies. , which is “Maintaining the No. 1 position in traditional medicine – focusing on investment and development on non-herbal medicine”.